NO20022793L - Amifile polymere samt polypeptidkonjugater inneholdende slike - Google Patents

Amifile polymere samt polypeptidkonjugater inneholdende slike

Info

Publication number
NO20022793L
NO20022793L NO20022793A NO20022793A NO20022793L NO 20022793 L NO20022793 L NO 20022793L NO 20022793 A NO20022793 A NO 20022793A NO 20022793 A NO20022793 A NO 20022793A NO 20022793 L NO20022793 L NO 20022793L
Authority
NO
Norway
Prior art keywords
well
conjugates containing
polypeptide conjugates
amphilic polymers
amphilic
Prior art date
Application number
NO20022793A
Other languages
English (en)
Other versions
NO20022793D0 (no
Inventor
Nnochiri N Ekwuribe
Original Assignee
Nobex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nobex Corp filed Critical Nobex Corp
Publication of NO20022793D0 publication Critical patent/NO20022793D0/no
Publication of NO20022793L publication Critical patent/NO20022793L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
NO20022793A 1999-12-13 2002-06-12 Amifile polymere samt polypeptidkonjugater inneholdende slike NO20022793L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/459,443 US6638906B1 (en) 1999-12-13 1999-12-13 Amphiphilic polymers and polypeptide conjugates comprising same
PCT/US2000/033592 WO2001041812A2 (en) 1999-12-13 2000-12-11 Amphiphilic polymers and polypeptide conjugates comprising same

Publications (2)

Publication Number Publication Date
NO20022793D0 NO20022793D0 (no) 2002-06-12
NO20022793L true NO20022793L (no) 2002-08-13

Family

ID=23824795

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022793A NO20022793L (no) 1999-12-13 2002-06-12 Amifile polymere samt polypeptidkonjugater inneholdende slike

Country Status (18)

Country Link
US (2) US6638906B1 (no)
EP (1) EP1237580A2 (no)
JP (1) JP2003516366A (no)
KR (1) KR20020068053A (no)
CN (1) CN1434725A (no)
AU (1) AU2087501A (no)
BR (1) BR0016339A (no)
CA (1) CA2394928A1 (no)
CZ (1) CZ20021990A3 (no)
HK (1) HK1049283A1 (no)
HU (1) HUP0300133A2 (no)
IL (1) IL150119A0 (no)
MX (1) MXPA02005885A (no)
NO (1) NO20022793L (no)
PL (1) PL359174A1 (no)
RU (1) RU2002118709A (no)
WO (1) WO2001041812A2 (no)
ZA (1) ZA200204603B (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9425138D0 (en) 1994-12-12 1995-02-08 Dynal As Isolation of nucleic acid
US6703381B1 (en) * 1998-08-14 2004-03-09 Nobex Corporation Methods for delivery therapeutic compounds across the blood-brain barrier
US20090281023A9 (en) * 2001-06-04 2009-11-12 Nobex Corporation Mixtures Of Calcitonin Drug-Oligomer Conjugates And Methods Of Use In Pain Treatment
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
AU2003202026A1 (en) 2002-01-16 2003-09-02 Dynal Biotech Asa Method for isolating nucleic acids and protein from a single sample
US20040062748A1 (en) * 2002-09-30 2004-04-01 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US8129330B2 (en) 2002-09-30 2012-03-06 Mountain View Pharmaceuticals, Inc. Polymer conjugates with decreased antigenicity, methods of preparation and uses thereof
US7648962B2 (en) * 2002-11-26 2010-01-19 Biocon Limited Natriuretic compounds, conjugates, and uses thereof
AU2003297583B2 (en) * 2002-11-26 2010-01-14 Biocon, Ltd Modified naturetic compounds, conjugates, and uses thereof
GB0229287D0 (en) * 2002-12-16 2003-01-22 Dna Res Innovations Ltd Polyfunctional reagents
CN1761680A (zh) 2002-12-26 2006-04-19 武田药品工业株式会社 肿瘤迁移抑制素衍生物及其用途
US7553930B2 (en) 2003-01-06 2009-06-30 Xencor, Inc. BAFF variants and methods thereof
AU2004285558A1 (en) * 2003-10-29 2005-05-12 Altus Pharmaceuticals Inc. Non-pancreatic proteases for controlling plasma cholecystokinin (CCK) concentration and for treating pain
SG153865A1 (en) 2004-06-25 2009-07-29 Takeda Pharmaceutical Metastin derivatives and use thereof
US8329958B2 (en) 2004-07-02 2012-12-11 Biocon Limited Combinatorial synthesis of PEG oligomer libraries
US8168222B2 (en) * 2004-09-07 2012-05-01 Board Of Regents Of The University Of Nebraska Amphiphilic polymer-protein conjugates and methods of use thereof
WO2006076471A2 (en) * 2005-01-12 2006-07-20 Nobex Corporation Bnp conjugates and methods of use
CA2606270A1 (en) * 2005-04-19 2006-10-26 Massachusetts Institute Of Technology Amphiphilic polymers and methods of use thereof
WO2007011959A2 (en) * 2005-07-15 2007-01-25 Quintessence Biosciences, Inc. Methods and compositions for extracting membrane proteins
US8404643B2 (en) 2005-12-22 2013-03-26 Takeda Pharmaceutical Company Limited Metastin derivatives and use thereof
JO3048B1 (ar) 2006-10-25 2016-09-05 Takeda Pharmaceuticals Co مشتقات متاستين واستخدامها
EP2314609B1 (en) * 2008-07-30 2016-11-30 Takeda Pharmaceutical Company Limited Metastin derivative and use thereof
RU2013141079A (ru) * 2011-03-01 2015-04-10 Ново Нордиск А/С Антагонические лиганды dr3
CN103740661B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
CN103740659B (zh) * 2012-05-10 2015-06-03 江南大学 一种提高酶热稳定性的方法
US20140039158A1 (en) * 2012-07-25 2014-02-06 Belrose Pharma, Inc. Polymeric conjugates and methods of preparing the same
CN106729735B (zh) * 2017-03-09 2020-05-12 国家纳米科学中心 一种pH敏感的多肽聚合物及其制备方法和应用
JP2021521231A (ja) * 2018-04-16 2021-08-26 メルク パテント ゲゼルシャフト ミット ベシュレンクテル ハフツングＭｅｒｃｋ Ｐａｔｅｎｔ Ｇｅｓｅｌｌｓｃｈａｆｔ ｍｉｔ ｂｅｓｃｈｒａｅｎｋｔｅｒ Ｈａｆｔｕｎｇ 熱安定性を改善するためのタンパク質製剤のための添加剤
KR20240026573A (ko) * 2022-08-22 2024-02-29 부산대학교 산학협력단 폴리소르베이트-숙신산-카르니틴 복합체 및 이를 포함하는 생리활성 물질 또는 약물 전달용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5411947A (en) 1989-06-28 1995-05-02 Vestar, Inc. Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
US5407683A (en) 1990-06-01 1995-04-18 Research Corporation Technologies, Inc. Pharmaceutical solutions and emulsions containing taxol
IE912365A1 (en) * 1990-07-23 1992-01-29 Zeneca Ltd Continuous release pharmaceutical compositions
WO1994005282A1 (en) 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5439686A (en) 1993-02-22 1995-08-08 Vivorx Pharmaceuticals, Inc. Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
US6191105B1 (en) 1993-05-10 2001-02-20 Protein Delivery, Inc. Hydrophilic and lipophilic balanced microemulsion formulations of free-form and/or conjugation-stabilized therapeutic agents such as insulin
US5359030A (en) 1993-05-10 1994-10-25 Protein Delivery, Inc. Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same
US5681811A (en) * 1993-05-10 1997-10-28 Protein Delivery, Inc. Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
US5932462A (en) 1995-01-10 1999-08-03 Shearwater Polymers, Inc. Multiarmed, monofunctional, polymer for coupling to molecules and surfaces
WO1997015671A1 (en) 1995-10-26 1997-05-01 Board Of Regents, The University Of Texas System Luminal cholecystokinin-releasing factor
AU735900B2 (en) 1996-03-12 2001-07-19 Pg-Txl Company, L.P. Water soluble paclitaxel prodrugs
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
WO1998058927A1 (en) 1997-06-20 1998-12-30 Baker Norton Pharmaceuticals, Inc. Soluble prodrugs of paclitaxel
US6495514B1 (en) * 1998-01-21 2002-12-17 Mercer University Method for reducing inflammation and inducing an analgesic effect and compounds thereof
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
KR100345214B1 (ko) * 1999-08-17 2002-07-25 이강춘 생체적합성 고분자가 수식된 펩타이드의 비점막 전달
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same

Also Published As

Publication number Publication date
MXPA02005885A (es) 2002-10-23
IL150119A0 (en) 2002-12-01
US6638906B1 (en) 2003-10-28
KR20020068053A (ko) 2002-08-24
NO20022793D0 (no) 2002-06-12
HK1049283A1 (zh) 2003-05-09
CA2394928A1 (en) 2001-06-14
EP1237580A2 (en) 2002-09-11
WO2001041812A2 (en) 2001-06-14
RU2002118709A (ru) 2004-02-27
CZ20021990A3 (cs) 2002-11-13
HUP0300133A2 (en) 2003-05-28
WO2001041812A3 (en) 2002-03-21
CN1434725A (zh) 2003-08-06
AU2087501A (en) 2001-06-18
PL359174A1 (en) 2004-08-23
BR0016339A (pt) 2002-08-27
US20040092449A1 (en) 2004-05-13
ZA200204603B (en) 2003-11-26
JP2003516366A (ja) 2003-05-13

Similar Documents

Publication Publication Date Title
NO20022793L (no) Amifile polymere samt polypeptidkonjugater inneholdende slike
DK1039922T3 (da) Forbedrede interferonpolymerkonjugater
DK1849831T3 (da) Epoxy-polysiloxan-polymersammensætning
NO20002038D0 (no) Uløselig insulinsammensetning
DK1019090T3 (da) Polymere camptothecin-derivater
DE69822495D1 (de) Nadellose injektionsstelle
DE69917815D1 (de) Polymere zusammensetzung
DE69707712D1 (de) Polymere enthaltend hochgepfropftkautschuk
DE69831912D1 (de) Biokompatible polymere
DE69828573D1 (de) Transparente leitfähige Polymere
NL1016364A1 (nl) Vuurvaste thermoplastische harssamenstelling.
DE69810602T2 (de) Hochtransparentes,farbpigmentiertes material mit hohem molekulargewicht
NO20021275D0 (no) Transgent produserte fusjonsproteiner
AT2958U3 (de) Einspritzsystem
FR2791348B1 (fr) POLYPEPTIDE Npt2B
PT1039908E (pt) Composicao de dispersao molecular com biodisponibilidade melhorada
NO975006L (no) Dragebr°nn
NO20012133L (no) Smertestillende kur
NO20021244D0 (no) Subenhet-optimaliserte fusjonsproteiner
DE60045468D1 (de) Feuerfeste thermoplastische Harzzusammensetzung
NO974831L (no) Kj°leelement
FI3094U1 (fi) Lääketasku
DE69804527D1 (de) Flaschenkasten
ATE257718T1 (de) Injektionsteil
UA1621S (uk) Пляшка

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application